The novel RARβ isoform β a potential target of retinoids in breast cancer

Current Cancer Drug Targets

Volumn 9, Issue 2, 2009, Pages 142-147

  Christov, Konstantin ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Breast cancer; Prevention; Rar isoform; Retinoid receptors; Retinoids

Indexed keywords

RETINOIC ACID; RETINOIC ACID RECEPTOR BETA; RETINOIC ACID RECEPTOR BETA2; RETINOIC ACID RECEPTOR BETA4; RETINOIC ACID RECEPTOR BETA5; RETINOID DERIVATIVE; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; RETINOIC ACID RECEPTOR; RETINOID;

5' UNTRANSLATED REGION; BREAST CANCER; BREAST CARCINOGENESIS; CANCER CELL; CANCER PREVENTION; CANCER RESISTANCE; CANCER THERAPY; DRUG SENSITIVITY; DRUG TARGETING; HUMAN; NONHUMAN; PROTEIN VARIANT; REVIEW; ANIMAL; BREAST TUMOR; DRUG EFFECT; FEMALE; GENETICS; METABOLISM;

5' UNTRANSLATED REGIONS; ANIMALS; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; FEMALE; HUMANS; RECEPTORS, RETINOIC ACID; RETINOIDS;

EID: 62549125005     PISSN: 15680096     EISSN: None     Source Type: Journal    
DOI: 10.2174/156800909787580953     Document Type: Review

References (38)

1. de The, H.; Marchio, T.; Tiollais, P. A.; Dejean, A. A novel steroid thyroid homone receptor-related gene inappropriately expressed in human hepatocellular carcinoma. Nature 1987, 330, 667-670.
2. Zelent, A.; Mendelsohn, P.; Kastner, P.; Krust, A.; Garnier, J. M.; Ruffenach, F. Differentially expressed isoforms of the mouse retionic acid receptor β are generated by usage of two promoters and alternative splicing. EMBO J. 1991, 70, 71-81.
3. Lotan, R. Retinoids in cancer chemoprevention. FASEB J. 1996, 70, 1031-1039.
4. Nagpal, S.; Zelent, A.; Chambon, P. RAR64, a retinoic acid receptor isoform is generated from RAR62 by alternative splicing and usage of a CUG initiator codon. Proc. Nat. Acad. Sci. USA 1992, 89, 2718-2722.
5. Chambone, P. A decade of molecular biology of retinoic acid receptors. FASEB J. 1996, 70, 940-954.
6. Veronesi, U.; Mariani, L.; Decensi, A.; Formelli, F.; Camerini, T.; Miceli, R.; Di Mauro, M. G.; Costa, A.; Marubini, E.; Sporn, M. B.; De Palo, G. Fifteen-year results of a randomized phase III trial of fenretinide to prevent second breast cancer. Ann. Oncol. 2007, 17, 1065-1071.
7. Liby, K. T.; Yore, M. M.; Sporn, M. B. Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancer. Nat. Rev. Cancer 2007, 7, 357-369.
8. de The, H.; Vivanco-Ruiz, M. D. M.; Tiollais, P. Identification of a retinoic acid response element in the retinoic acid receptor gene. Nature 1990, 343, 177-180.
9. Houle, B.; Pelletier, M.; Wu, J.; Gooddyer, C.; Bradley, W. E. Fetal isoform of human retinoic acid receptor beta expressed in small cell lung cancer lines. Cancer Res. 1994, 54, 365-369.
10. Youssef, E. M.; Issa, J. P.; Lotan, R. Regulation of RAR betal expression in head and neck cancer cells by cell density-dependent chromatin remodeling. Cancer Biol. Therapy 2004, 70, 1002-1006.
11. Petty, W. J.; Li, N.; Biddle, A.; Bounds, R.; Nitkin, C.; Ma, Y.; Dragnev, K. H.; Freemantle, S. J.; Dmitrovsky, E. A novel retinoic acid receptor beta isoform and retinoid resistance in lung carcinogenesis. J. Natl. Cancer Inst. 2005, 97, 1645-1651.
12. Goelden, U.; Ukena, S.; Pfoertner, S.; Hofmann, R.; Buer, J.; Schrader, A. J. RAR beta (1) overexpression in chromophobe renal cell carcinoma: A novel target for therapeutic intervention? Exp. Oncol. 2005, 27, 220-224.
13. Widschwendter, W.; Berger, J.; Daxenbichler, G.; Muller-Holzner, E. A.; Widschwendter, A.; Mayr, A.; Marth, C.; Zeimet, A. G. Loss of retinoic acid receptor beta expression in breast cancer and morphologically normal adjacent tissue but not in the normal breast tissue distant from the cancer. Cancer Res. 1997, 57, 4158-4161.
14. Xu, X. C.; Sneige, N.; Liu, X.; Lee, J. J.; Lukmanji, F.; Hortobagyi, G. Progressive decrease in nuclear retinoic acid receptor beta messenger RNA level during breast carcinogenesis. Cancer Res. 1997, 57, 4992-4996.
15. Sirchia, S. M.; Ferguson, A. T.; Sironi, E.; Subramanyan, A.; Orlandi, R.; Sukumar, S.; Sacchi, N. Evidence of epigenetic changes affecting the chromatin state of the retinoic acid receptor F12 promoter in breast cancer cells. Oncogene 2000, 79, 1556-1563.
16. Sirchia, S. M.; Ren, M.; Pili, R.; Sironi, E.; Somenzi, G. R.; Ghidoni, R.; Sacci, N. Endogenous reactivation of the RAR beta 2 tumor suppressor gene epigenetically silenced in breast cancer. Cancer Res. 2002, 62, 2455-2461.
17. Seewald, V. L.; Jonhson, B. S.; Parker, M. B.; Collins, S. J.; Swisshelm, K. Expression of retinoic acid receptor beta mediates retinoic acid induced growth arrest and apoptosis in breast cancer cells. Cell Growth Differ. 1995, 6, 1077-1088.
18. Treuting, P. M.; Chen, L. I.; Buetow, B. S.; Zeng, W.; Birkebak, T. A.; Seewaldt, V. L.; Sommer, K. M.; Emond, M.; Maggio-Price, L.; Swisshelm, K. Retinoic acid receptor beta 2 inhibition of metastasis in mouse mammary gland xenografts. Breast Cancer Res. Treat. 2002, 72, 79-88.
19. Altucci, A.; Gronemeyer, H. The promise of retinoids to fight against cancer. Nat. Rev. Cancer 2001, 7, 181-193.
20. Bastien, J.; Rochette-Egly, C. Nuclear retinoid receptors and the transcription of retinoid-target genes. Gene 2004, 328, 1-16.
21. Sommer, K. M.; Chen, L. I.; Treuring, P. M.; Smith, L. T.; Swisshelm, K. Elevated retinoic acid receptor (34 protein in human breast tumor cells with nuclear and cytoplasmic localization. Proc. Natl. Acad. Sci. USA 1999, 96, 8651-8656.
22. Chen, L. I.; Sommer K.; Swisshelm, K. Downstream codons in the retinoic acid recepor β2 and. β4 mRNAs initiate translation of a protein isofom that disrupts retinoid activated transcription. J. Biol. Chem. 2002, 277, 35411-35421.
23. Swift, M. E.; Walden, B.; Wayner, E.; Swisshelm, K. Truncated RAR beta isoform enhances proliferation and retinoid resistance. J. Cell Physiol. 2006, 209, 718-725.
24. Hayashi, K.; Goodison, S.; Urquidi, V.; Tarin, D.; Lotan, R.; Tahara, E. Differential effects of retinoic acid on the growth of isogenic metastatic and non-metastatic breast cancer cell lines and their association with distinct expression of retinoic acid receptor β isoforms 2 and 4. Int. J. Oncol. 2003, 22, 623-629.
25. Berand, J.; Gaboury, L.; Landers, M.; Rependigny, Y. D.; Houle, B.; Kothary, R.; Bradley, W. D. C. Hyperplasia and tumors in lung, breast and other tissues in mice carrying a RARp4 - like transgene. EMBO J. 1994, 13, 5570-5580.
26. Peng, X.; Mehta, R. G.; Tonetti, D. A.; Christov, K. Identification of novel RARp2 transcript variants in normal and cancerous breast epithelial cells. Oncogene 2005, 24, 1296-1301.
27. Peng, X.; Maruo, T.; Cao, Y.; Punj, V.; Mehta, R. R.; Das Gupta, T.; Christov, K. Identification of a novel RARβ isoform (β5) directed by a distinct promoter P3 and mediated by retinoic acid in human breast epithelial cells. Cancer Res. 2004, 64, 8911-8918.
28. Liu, Y.; Lee, M. O.; Wang, H. G.; Li, Y.; Hashimoto, Y.; Klaus, M.; Reed, J. C.; Zhang, K. Retinoic acid receptor β mediates the growth-inhibitory effect of retinoic acid by promoting apoptosis in human breast cancer cells. Mol. Cell Biol. 1996, 16, 1138-1149.
29. Shen, Q.; Brown, P. Novel agents for the prevention of breast cancer: targeting transcription factors and signal transduction pathways. J. Mammary Gland Biol. Neopl. 2003, 8, 45-61.
30. Smith, L. C.; O'Malley, B. W. Co-regulator function: A key to understanding tissue specificity of selective receptor modulators. Endocrine Res. 2004, 26, 45-71.
31. Tanaka, T.; Concepcion, R.; De Luca, L. M. Involvement of all- trans-retinoic acid in the breakdown of retinoic acid receptors alpha and gamma through proteasomes in MCF-7 human breast cancer cells. Biochem. Pharmacol. 2001, 61, 1347-1355.
32. Chang, D.; Broudy, E.; Dokmanovic, M.; Zhu, H.; Ruth, A.; Xang, Y.; Kandel, E. S.; Lausch, E.; Christov, K.; Roninson, I. B. A senescence-like phenotype distinguishes tumor cells that undergo terminal prolifereation arrest after exposure to anticancer agents. Cancer Res. 1999, 59, 3761-3767.
33. Peng, X.; Yun, D.; Christov, K. Breast cancer progression in MCF10A series of cell lines is associated with alterations in retinoic acid and retinoid X receptors and with differential response to retinoids. Int. J. Oncol. 2004, 22, 623-629.
34. Peng, X.; Grawes, J.; Shilkaitis, A.; Christov, K. Retinoids differentially affect breast cancer development in the MCF10AT series of cell lines. Cancer Lett. 2004, 222, 153-163.
35. Xu, X. C. Tumor suppressor activity of retinoic acid receptor-β in cancer. Cancer Lett. 2006, 253, 14-24.
36. Vucetic, Z.; Zhang, Z.; Zhao, J.; Wang, F.; Soprano, K. J.; Soprano, D. R.; Acinus-S' represses RAR-regulated gene expression through interaction with the B-domain. Mol. Cell. Biol. 2008, 128, 1199-1207.
37. Huang, J.; Liang, Z. D.; Wu, T. T.; Hoque, A.; Chen, H.; Jiang, Y.; Zhang, H.; Xu, X. C. Tumor-suppressive effect of retinoid receptor-induced gene-1 (RRIG1) in esophageal cancer. Cancer Res. 2007, 67, 1589-1593.
38. Soprano, D. R.; Qin, P.; Soprano, K. J. Retinoic acid receptors and cancer. Ann. Rev. Nutr. 2004, 24, 201-221.